Form 4: Prestige Consumer Healthcare Executive Exercises Options and Sells Shares
SEC Form 4 Filing
Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, exercised stock options and sold shares on March 3, 2025.
Summary
- On March 3, 2025, Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare Inc., exercised employee stock options to acquire 6,297 shares of common stock at a price of $44.33 per share.
- Simultaneously, Ms. Fritz sold 6,297 shares of common stock at a weighted average price of $85.39, with individual sales ranging from $85.00 to $86.01.
- Following these transactions, Ms. Fritz directly owns 18,835 shares of Prestige Consumer Healthcare Inc.
- The exercised options were granted previously and vested in three equal installments on May 2, 2022, May 2, 2023, and May 2, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies like Prestige Consumer Healthcare.
- Comparing the volume and frequency of insider transactions at Prestige to peers such as Church & Dwight or The Clorox Company could provide a benchmark for assessing the significance of this activity.
- However, without additional context regarding overall trading volumes and insider ownership percentages, it's difficult to definitively assess whether this transaction is unusual or indicative of a broader trend.
Stakeholder Impact
- The transaction may have a minor impact on shareholders, as insider transactions are often scrutinized for signals about company performance.
- The impact on employees, customers, suppliers, and creditors is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 08/07/2018 | Date of power of attorney granted to William P'Pool. |
| 05/02/2022 | First vesting date of employee stock options (2,099 shares). |
| 05/02/2023 | Second vesting date of employee stock options (2,099 shares). |
| 05/02/2024 | Third vesting date of employee stock options (2,099 shares). |
| 03/03/2025 | Date of transaction: exercise of options and sale of shares. |
| 03/05/2025 | Date of Form 4 filing. |
| 05/03/2031 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.